Carprofen
(right click,save link as to download,it is a temp file,please download as soon as possible, you can also use CTRL+S to save the whole html page)
Basic Info
| Common Name | Carprofen(F05661) |
| 2D Structure | |
| FRCD ID | F05661 |
| CAS Number | 53716-49-7 |
| PubChem CID | 2581 |
| Formula | C15H12ClNO2 |
| IUPAC Name | 2-(6-chloro-9H-carbazol-2-yl)propanoic acid |
| InChI Key | PUXBGTOOZJQSKH-UHFFFAOYSA-N |
| InChI | InChI=1S/C15H12ClNO2/c1-8(15(18)19)9-2-4-11-12-7-10(16)3-5-13(12)17-14(11)6-9/h2-8,17H,1H3,(H,18,19) |
| Canonical SMILES | CC(C1=CC2=C(C=C1)C3=C(N2)C=CC(=C3)Cl)C(=O)O |
| Isomeric SMILES | CC(C1=CC2=C(C=C1)C3=C(N2)C=CC(=C3)Cl)C(=O)O |
| Synonyms |
Rimadyl
Carprofene [INN-French]
carprofen
53716-49-7
2-(6-Chloro-9H-carbazol-2-yl)propanoic acid
Imadyl
Ridamyl
Carprofene
Carprofeno
Carprofenum
|
| Classifies |
Predicted: Pollutant
|
| Update Date | Nov 13, 2018 17:07 |
Chemical Taxonomy
| Kingdom | Organic compounds |
| Superclass | Organoheterocyclic compounds |
| Class | Indoles and derivatives |
| Subclass | Carbazoles |
| Intermediate Tree Nodes | Not available |
| Direct Parent | Carbazoles |
| Alternative Parents | |
| Molecular Framework | Aromatic heteropolycyclic compounds |
| Substituents | Carbazole - Indole - Aryl chloride - Aryl halide - Benzenoid - Pyrrole - Heteroaromatic compound - Carboxylic acid derivative - Carboxylic acid - Monocarboxylic acid or derivatives - Azacycle - Organochloride - Organohalogen compound - Organic oxygen compound - Organic oxide - Organic nitrogen compound - Carbonyl group - Organonitrogen compound - Organooxygen compound - Hydrocarbon derivative - Organopnictogen compound - Aromatic heteropolycyclic compound |
| Description | This compound belongs to the class of organic compounds known as carbazoles. These are compounds containing a three ring system containing a pyrrole ring fused on either side to a benzene ring. |
Properties
| Property Name | Property Value |
|---|---|
| Molecular Weight | 273.716 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 2 |
| Complexity | 362 |
| Monoisotopic Mass | 273.056 |
| Exact Mass | 273.056 |
| XLogP | 4 |
| Formal Charge | 0 |
| Heavy Atom Count | 19 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Isotope Atom Count | 0 |
| Covalently-Bonded Unit Count | 1 |
ADMET
| Model | Result | Probability |
|---|---|---|
| Absorption | ||
| Blood-Brain Barrier | BBB+ | 0.9742 |
| Human Intestinal Absorption | HIA+ | 1.0000 |
| Caco-2 Permeability | Caco2+ | 0.5595 |
| P-glycoprotein Substrate | Non-substrate | 0.7062 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9850 |
| Non-inhibitor | 0.9319 | |
| Renal Organic Cation Transporter | Non-inhibitor | 0.8485 |
| Distribution | ||
| Subcellular localization | Mitochondria | 0.4735 |
| Metabolism | ||
| CYP450 2C9 Substrate | Non-substrate | 0.7405 |
| CYP450 2D6 Substrate | Non-substrate | 0.8318 |
| CYP450 3A4 Substrate | Non-substrate | 0.6389 |
| CYP450 1A2 Inhibitor | Inhibitor | 0.6573 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.7193 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9481 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.7037 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.8308 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.7940 |
| Excretion | ||
| Toxicity | ||
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9725 |
| Non-inhibitor | 0.8697 | |
| AMES Toxicity | Non AMES toxic | 0.9133 |
| Carcinogens | Non-carcinogens | 0.8521 |
| Fish Toxicity | High FHMT | 0.9695 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9490 |
| Honey Bee Toxicity | Low HBT | 0.5577 |
| Biodegradation | Not ready biodegradable | 0.9874 |
| Acute Oral Toxicity | II | 0.7358 |
| Carcinogenicity (Three-class) | Non-required | 0.5366 |
| Model | Value | Unit |
|---|---|---|
| Absorption | ||
| Aqueous solubility | -4.4286 | LogS |
| Caco-2 Permeability | 1.0471 | LogPapp, cm/s |
| Distribution | ||
| Metabolism | ||
| Excretion | ||
| Toxicity | ||
| Rat Acute Toxicity | 3.4155 | LD50, mol/kg |
| Fish Toxicity | 0.8693 | pLC50, mg/L |
| Tetrahymena Pyriformis Toxicity | 0.3069 | pIGC50, ug/L |
MRLs
| Food | Product Code | Country | MRLs | Application Date | Notes |
|---|---|---|---|---|---|
| Other Terrestrial Mammals,Edible Offal | Japan | 1ppm | |||
| Cattle,Edible Offal | Japan | 1ppm | |||
| Other Terrestrial Mammals,Kidney | Japan | 1ppm | |||
| Cattle,Kidney | Japan | 1ppm | |||
| Other Terrestrial Mammals,Liver | Japan | 1ppm | |||
| Cattle,Liver | Japan | 1ppm | |||
| Other Terrestrial Mammals,Fat | Japan | 1ppm | |||
| Cattle,Fat | Japan | 1ppm | |||
| Other Terrestrial Mammals,Muscle | Japan | 0.5ppm | |||
| Cattle,Muscle | Japan | 0.5ppm |
References
| Title | Journal | Date | Pubmed ID |
|---|---|---|---|
| The use of toxicokinetics and exposure studies to show that carprofen in cattle tissue could lead to secondary toxicity and death in wild vultures. | Chemosphere | 2018 Jan | 28985539 |
| Sterility and Stability of Diluted Carprofen in a Multidose Vial in theLaboratory Animal Setting. | J Am Assoc Lab Anim Sci | 2017 May 1 | 28535864 |
| Effect of sorbitol, single, and multidose activated charcoal administration oncarprofen absorption following experimental overdose in dogs. | J Vet Emerg Crit Care (San Antonio) | 2015 Sep-Oct | 25891141 |
| A multiresidue liquid chromatographic/tandem mass spectrometric method for thedetection and quantitation of 15 nonsteroidal anti-inflammatory drugs (NSAIDs) inbovine meat and milk. | Anal Bioanal Chem | 2015 Jun | 25814273 |
| Pharmacological effects of a C-phycocyanin-based multicomponent nutraceutical in an in-vitro canine chondrocyte model of osteoarthritis. | Can J Vet Res | 2015 Jul | 26130858 |
| Randomised trial of the bioavailability and efficacy of orally administeredflunixin, carprofen and ketoprofen in a pain model in sheep. | Aust Vet J | 2015 Aug | 26220318 |
| Short communication: Effects of analgesic use postcalving on cow welfare andproduction. | J Dairy Sci | 2014 Feb | 24290817 |
| Determination of non-steroidal anti-inflammatory drugs and their metabolites inmilk by liquid chromatography-tandem mass spectrometry. | Anal Bioanal Chem | 2012 Jul | 22395450 |
| Assessment of carprofen and buprenorphine on recovery of mice after surgicalremoval of the mammary fat pad. | J Am Assoc Lab Anim Sci | 2010 Sep | 20858363 |
| Confirmatory analysis of non-steroidal anti-inflammatory drugs in bovine milk by high-performance liquid chromatography with fluorescence detection. | J Chromatogr A | 2010 Apr 23 | 20227702 |
| Systematic review of the management of canine osteoarthritis. | Vet Rec | 2009 Apr 4 | 19346540 |
| Effect of carprofen treatment following experimentally induced Escherichia colimastitis in primiparous cows. | J Dairy Sci | 2005 Jul | 15956299 |
| Protective effect of the chondroprotective agent Cosequin DS on bovine articular cartilage exposed in vitro to nonsteroidal antiinflammatory agents. | Vet Ther | 2002 Summer | 19750743 |
| Assessment of the postoperative discomfort of intra-auricularly hypophysectomizedrats. | Lab Anim | 2002 Apr | 11943078 |
| Effects of butorphanol and carprofen on the minimal alveolar concentration ofisoflurane in dogs. | J Am Vet Med Assoc | 2000 Oct 1 | 11019709 |
| Pharmacodynamics and pharmacokinetics of carprofen, a non-steroidal anti-inflammatory drug, in healthy cows and cows with Escherichia coli endotoxin-induced mastitis. | J Vet Pharmacol Ther | 1991 Sep | 1744930 |